Products
Platform
Research
Market
Learn
Compare Mirae Asset Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 2.0 | 5.0 |
Min SIP Amount | ₹99 | ₹500 |
Expense Ratio | 1.93 | 1.93 |
NAV | ₹38.58 | ₹432.23 |
Fund Started | 11 Jun 2018 | 04 Jun 1999 |
Fund Size | ₹2908.21 Cr | ₹4026.55 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
2.0
5.0
Min SIP Amount
₹99
₹500
Expense Ratio
1.93
1.93
NAV
₹38.58
₹432.23
Fund Started
11 Jun 2018
04 Jun 1999
Fund Size
₹2908.21 Cr
₹4026.55 Cr
Exit Load
Exit load of 1% if redeemed within 1 year.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 1.88% | 8.32% |
3 Year | 21.75% | 26.95% |
5 Year | 18.42% | 20.27% |
1 Year
1.88%
8.32%
3 Year
21.75%
26.95%
5 Year
18.42%
20.27%
Holding Analysis
Equity | 99.63% | 97.60% |
Cash | 0.37% | 2.33% |
Equity
99.63%
97.60%
Cash
0.37%
2.33%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.74% |
Divi's Laboratories Ltd. | 8.02% |
Glenmark Pharmaceuticals Ltd. | 7.24% |
Aurobindo Pharma Ltd. | 6.41% |
Cipla Ltd. | 6.11% |
Apollo Hospitals Enterprise Ltd. | 5.98% |
Lupin Ltd. | 4.94% |
Dr. Reddy's Laboratories Ltd. | 4.13% |
Krishna Institute of Medical Sciences Ltd | 3.81% |
Cohance Lifesciences Ltd. | 3.56% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.44% |
Divi's Laboratories Ltd. | 7.21% |
Max Healthcare Institute Ltd. | 6.50% |
Cipla Ltd. | 4.63% |
Lonza Group Ag | 4.09% |
Lupin Ltd. | 4.02% |
Gland Pharma Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.57% |
Acutaas Chemicals Ltd. | 3.30% |
Krishna Institute of Medical Sciences Ltd | 3.26% |
Fund Manager
Name | Vrijesh Kasera | Tanmaya Desai |
Start Date | 03 Feb 2023 | 27 Jun 2011 |
Name
Vrijesh Kasera
Tanmaya Desai
Start Date
03 Feb 2023
27 Jun 2011
About Fund
Description | The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 11 Jun 2018 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
11 Jun 2018
04 Jun 1999
